{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:37:45Z","timestamp":1765827465545,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T00:00:00Z","timestamp":1455321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jdcr.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,4,15]],"date-time":"2016-04-15T21:46:16Z","timestamp":1460756776000},"page":"146-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interferon alfa\u2013induced sarcoidosis resolving without drug withdrawal"],"prefix":"10.1016","volume":"2","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Ortiz Salvador","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mercedes","family":"Victoria Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Subiabre","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Alegre de Miquel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"P\u00e9rez Ferriols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdcr.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archderm.141.7.865","article-title":"Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a\u00a0case report and review of the literature","volume":"141","author":"Hurst","year":"2005","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jdcr.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1055\/s-2000-10023","article-title":"[Pulmonal sarcoidosis: A\u00a0rare side effect of interferon-alpha treatment for chronic hepatitis C infection]","volume":"38","author":"Pohl","year":"2000","journal-title":"Z Gastroenterol"},{"issue":"9","key":"10.1016\/j.jdcr.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1346-8138.12581","article-title":"Development of sarcoidosis during beta-interferon therapy for melanoma","volume":"41","author":"Shiki","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jdcr.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.12659\/AJCR.890180","article-title":"Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C","volume":"15","author":"Trien","year":"2014","journal-title":"Am J Case Rep"},{"issue":"12","key":"10.1016\/j.jdcr.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jfma.2014.07.008","article-title":"Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C","volume":"113","author":"Chiang","year":"2014","journal-title":"J\u00a0Formos Med Assoc"},{"issue":"11","key":"10.1016\/j.jdcr.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jdv.13246","article-title":"TNF-alpha: a treatment target or cause of sarcoidosis?","volume":"29","author":"Amber","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdcr.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaad.2003.06.013","article-title":"Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C","volume":"50","author":"Rogers","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2016.02.003_bib8","first-page":"432","article-title":"Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C\u2013a case report and review of the literature","volume":"68","author":"Bolukbas","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"issue":"8","key":"10.1016\/j.jdcr.2016.02.003_bib9","first-page":"450","article-title":"[Pulmonary sarcoidosis associated with pegylated interferon in the treatment of chronic hepatitis C]","volume":"28","author":"Ubina-Aznar","year":"2005","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jdcr.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-4632.2010.04728.x","article-title":"Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature","volume":"50","author":"Lopez","year":"2011","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0953-6205(03)00078-5","article-title":"Sarcoidosis and interferon therapy: report of five cases and review of the literature","volume":"14","author":"Leclerc","year":"2003","journal-title":"Eur J Intern Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512616000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512616000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:16:14Z","timestamp":1762474574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512616000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2352512616000199"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2016.02.003","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon alfa\u2013induced sarcoidosis resolving without drug withdrawal","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}